References

Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070

10.1038/s41571-021-00514-z · 2021 · External reference

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2024 · External reference

Digestive cancers: mechanisms, therapeutics and management

10.1038/s41392-024-02097-4 · 2025 · External reference

The WHO global landscape of cancer clinical trials

10.1038/s41591-025-03926-x · 2025 · External reference

The role of ROS in tumour development and progression

10.1038/s41568-021-00435-0 · 2022 · External reference

Glutathione metabolism in ferroptosis and cancer therapy

2025 · External reference

Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers

10.1186/s12943-025-02375-x · 2025 · External reference

Targeting ROS in cancer: rationale and strategies

10.1038/s41573-024-00979-4 · 2024 · External reference

Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer

2025 · External reference

Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer

10.1016/j.redox.2024.103286 · 2024 · External reference

The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications

10.1186/s13045-026-01780-z · 2026 · External reference

Molecular principles underlying aggressive cancers

10.1038/s41392-025-02129-7 · 2025 · External reference

Anticancer drug resistance: an update and perspective

2021 · External reference

Sensitization strategy for sonodynamic therapy

10.7150/thno.130498 · 2026 · External reference

A redox-responsive nanoparticle with RGD-targeted effect for photo-chemo therapy of triple-negative breast cancer

2025 · External reference

Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy

2021 · External reference

Ultrasound-actuated ion homeostasis perturbator for oxidative damage-augmented Ca2+ interference therapy and combined immunotherapy

2025 · External reference

Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions

10.7150/thno.80887 · 2023 · External reference

Advances in iron-based chemodynamic anti-cancer therapy

2026 · External reference

Phototherapy in cancer treatment: strategies and challenges

10.1038/s41392-025-02140-y · 2025 · External reference

Emerging sonodynamic therapy-based nanomedicines for cancer immunotherapy

2022 · External reference

Synergistic nanobubble-mediated sonodynamic therapy and MicroRNA immunotherapy suppresses hepatocellular carcinoma

2026 · External reference

Combination of sonodynamic with temozolomide inhibits C6 glioma migration and promotes mitochondrial pathway apoptosis via suppressing NHE-1 expression

10.1016/j.ultsonch.2017.05.013 · 2017 · External reference

Self-enhanced ROS-responsive camptothecin prodrug nanoparticles elicit safe and efficient intravesical instillation therapy of bladder cancer

2025 · External reference

Glutathione-responsive nanoparticles of camptothecin prodrug for cancer therapy

2022 · External reference

Co-delivery of camptothecin and MiR-145 by lipid nanoparticles for MRI-visible targeted therapy of hepatocellular carcinoma

10.1186/s13046-024-03167-9 · 2024 · External reference

Unleashing the potential of camptothecin: exploring innovative strategies for structural modification and therapeutic advancements

10.1021/acs.jmedchem.3c02115 · 2024 · External reference

A biomimetic multimodal nanoplatform combining neutrophil-coated two-dimensional metalloporphyrinic framework nanosheet and exendin-4 to treat obesity-related osteoporosis

2025 · External reference

Precise clearance of intracellular MRSA via internally and externally mediated bioorthogonal activation of micro/nano hydrogel microspheres

2024 · External reference

The application of nanoparticles targeting cancer-associated fibroblasts

10.2147/ijn.s447350 · 2024 · External reference

Stimuli-responsive polymer-based nanosystems for cancer theranostics

10.1021/acsnano.3c06019 · 2023 · External reference

A pH and glutathione-responsive carbon monoxide-driven nano-herb delivery system for enhanced immunotherapy in colorectal cancer

10.1016/j.jconrel.2024.10.043 · 2024 · External reference

Sonodynamic therapy: rapid progress and new opportunities for non-invasive tumor cell killing with sound

2022 · External reference

Principles of nanoparticle design for overcoming biological barriers to drug delivery

10.1038/nbt.3330 · 2015 · External reference

High-load gemcitabine inorganic-organic hybrid nanoparticles as an image-guided tumor-selective drug-delivery system to treat pancreatic cancer

2023 · External reference

Pure drug nano-assemblies: a facile carrier-free nanoplatform for efficient cancer therapy

10.1016/j.apsb.2021.08.012 · 2022 · External reference

Sorafenib and tetrakis (4-carboxyphenyl) porphyrin assembled nanoparticles for synergistic targeted chemotherapy and sonodynamic therapy of hepatocellular carcinoma

10.1039/d3bm01994b · 2024 · External reference

Open-shell nanosensitizers for glutathione responsive cancer sonodynamic therapy

2022 · External reference

A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration

10.1016/j.jconrel.2023.01.038 · 2023 · External reference

Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy

10.17305/bjbms.2022.7194 · 2022 · External reference

Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis

10.18632/oncotarget.9878 · 2016 · External reference